Analyst Ratings for Regeneron Pharma (REGn)
REGn Rating Summary
REGn Price Target Summary
- Highest: $1,000.00 (Guggenheim)
- Lowest: $641.00 (Leerink)
- Average: $838.85
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$838.85 (+6.1%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
Rating Score: 6.3 / 10
Percentile Rank: 66%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/1/2026 | Argus | Jasper Hellweg | Upgrade | Buy (Hold) |
850.00 (N/A) |
758.27 (790.74) |
4.28% | Details |
| 5/18/2026 | Leerink | Andrew Berens | Downgrade | Market Perform (Outperform) |
641.00 (N/A) |
698.25 (790.74) |
13.25% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
